Medicinal cannabis prescriptions surge to more than 72,000 in a year
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainPolicyResearchSafetyIndustryNeurologyMental Health Why This Matters Clinicians need to understand this surge in…
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyPainAnxietyMental HealthIndustryNeurology Why This Matters This NIDA-funded Phase 3 trial represents…
Flying with THC Cartridges: What the Law Actually Says
Vape pens and THC cartridges travel in the same pocket but under entirely different legal frameworks. State legalization creates a coherent signal that airports do not honor. The risk is not theoretical, and it is not distributed evenly across the…
GLP-1 Plus SGLT2 Therapy: What an Exploratory Cardiorenal Meta-Analysis Found
GLP-1 SGLT2 combination cardiorenal outcomes were examined across 16 randomized trial datasets. Combination use ranked favorably for cardiovascular and kidney outcomes. The mostly nonrandomized subgroup comparisons make the findings hypothesis-generating…
Ireland Finds High-Risk Synthetic Cannabinoids in CBD and Cannabis Products
Ireland synthetic cannabinoid warning: Ireland's health service found high-risk synthetic and semi-synthetic cannabinoids in tested vapes and vape liquids. Products sold as CBD, cannabis, or THC may not match their labels. The report supports product…
Dulaglutide vs Insulin in Adolescents With Thalassaemia-Related Diabetes
dulaglutide thalassaemia diabetes trial: In an open-label randomized trial of 80 adolescents with transfusion-dependent beta-thalassaemia and diabetes, weekly dulaglutide improved glucose variability and several metabolic measures more than basal-bolus…
What are the health risks from synthetic cannabinoids?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SafetyTHCMental HealthNeurologyResearchPolicyAnxiety Why This Matters Synthetic cannabinoids pose greater health risks…
Virginia family fears new hemp law will cut off daughter’s longtime seizure treatment
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyHempPolicyPediatricsSafetyResearchCBD Clinical Summary Virginia’s recently enacted hemp legislation…
Study Finds CBD Improves Social Deficits, Hyperactivity and Repetitive Behaviors in Autism Model
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDNeurologyPediatricsMental HealthSafetyAnxiety Why This Matters Clinicians treating autism spectrum disorder…
Does Cannabis Lower Blood Sugar *Nkzlj1NKw*
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyDosingHempPolicy Why This Matters Clinicians should be aware that while patients increasingly ask…
